tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

MRNA Stock Latest News

GBIO Soars on Teaming Up with Moderna
Market NewsGBIO Soars on Teaming Up with Moderna
4d ago
GBIO
MRNA
Moderna, Generation Bio enter collaboration for non-viral genetic medicines
The FlyModerna, Generation Bio enter collaboration for non-viral genetic medicines
4d ago
GBIO
MRNA
Generation Bio, Moderna announce strategic collaboration
The FlyGeneration Bio, Moderna announce strategic collaboration
4d ago
GBIO
MRNA
Moderna CEO defends $130 price of Covid-19 vaccine, Reuters reports
The FlyModerna CEO defends $130 price of Covid-19 vaccine, Reuters reports
5d ago
MRNA
Senate Health, Ed, Labor & Pensions Committee to hold a hearing
The FlySenate Health, Ed, Labor & Pensions Committee to hold a hearing
5d ago
MRNA
Senate Health, Ed, Labor & Pensions Committee to hold a hearing
The FlySenate Health, Ed, Labor & Pensions Committee to hold a hearing
6d ago
MRNA
FDA moving towards authorizing second omicron booster, WSJ reports
The FlyFDA moving towards authorizing second omicron booster, WSJ reports
6d ago
PFE
BNTX
Moderna Mulls COVID-19 Vaccine Price at $130
Market NewsModerna Mulls COVID-19 Vaccine Price at $130
6d ago
MRNA
Senate Health, Ed, Labor & Pensions Committee to hold a hearing
The FlySenate Health, Ed, Labor & Pensions Committee to hold a hearing
12d ago
MRNA
Moderna announces two presentations on mRNA-4157/V940 at AACR
The FlyModerna announces two presentations on mRNA-4157/V940 at AACR
13d ago
MRNA
Moderna Gains on Cowen Remarks
Market NewsModerna Gains on Cowen Remarks
14d ago
MRNA
Moderna upgraded to Outperform from Market Perform at TD Cowen
The FlyModerna upgraded to Outperform from Market Perform at TD Cowen
15d ago
MRNA
Moderna expands U.S. presence, plans to hire 2,000 by end of 2023
The FlyModerna expands U.S. presence, plans to hire 2,000 by end of 2023
17d ago
MRNA
Moderna sees several disease growth opportunities, says TD Cowen
The FlyModerna sees several disease growth opportunities, says TD Cowen
20d ago
MRNA
Moderna CEO pushes back on pricing plans for Covid-19 shot, WSJ reports
The FlyModerna CEO pushes back on pricing plans for Covid-19 shot, WSJ reports
20d ago
MRNA
Moderna initiated with an Outperform at RBC Capital
The FlyModerna initiated with an Outperform at RBC Capital
26d ago
MRNA
Moderna, Pfizer: Top mRNA Innovator Stocks are Oversold
Stock Analysis & IdeasModerna, Pfizer: Top mRNA Innovator Stocks are Oversold
27d ago
PFE
MRNA
Moderna price target lowered to $200 from $225 at Deutsche Bank
The FlyModerna price target lowered to $200 from $225 at Deutsche Bank
27d ago
MRNA
SVB downgrades Moderna to Underperform as COVID boom reverses
The FlySVB downgrades Moderna to Underperform as COVID boom reverses
1M ago
ABUS
ALNY
Moderna downgraded to Underperform from Market Perform at SVB Securities
The FlyModerna downgraded to Underperform from Market Perform at SVB Securities
1M ago
MRNA
Moderna Earnings Update: Did it Beat Estimate Forecasts?
Earning ReleasesModerna Earnings Update: Did it Beat Estimate Forecasts?
1M ago
MRNA
Moderna price target lowered to $185 from $205 at Morgan Stanley
The FlyModerna price target lowered to $185 from $205 at Morgan Stanley
1M ago
MRNA
tipranks
TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions.
Find Us on
twitterstocktwitsfacebooklinkedininstagram
Newsletter SubscriptionEnter your email to receive our newsletter
iosandroid
SitemapTerms of UsePrivacy PolicyFAQ
Research ToolsTop Smart Score StocksTrending StocksDaily Stock RatingsStock ScreenerStock ComparisonAnalysts' Top StocksDaily Insider TransactionsInsiders' Hot StocksExpert CenterEtf Center
CalendarsEarnings CalendarDividend CalendarIPO CalendarStock Market Holidays
EducationGlossaryTipRanks Labs
PlansPlans & PricingAPI for Institutions
CompanyAbout TipRanksContact UsReviews
Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.